ABEO Market Cap History
Below is a table of the ABEO market cap history going back to 10/24/2014:

Date ABEO Market Cap

Also see: ABEO Shares Outstanding History
and ABEO YTD Return
ABEO Historical Market Cap:
+20.84% CAGR
ABEO Historical Market Cap: +20.84% CAGR

Mouse over chart for data details
10/24/2014 ...8/1/2022
Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s primary clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, which is in the pivotal Phase 3 VIITAL™ clinical trial. Co. is developing additional adeno-associated virus (AAV)-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM™ capsid platform that Co. has licensed from University of North Carolina at Chapel Hill, and internal AAV vector research programs. We show 34 historical shares outstanding datapoints in our ABEO shares outstanding history coverage, used to compute ABEO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ABEO market cap history over the course of time is important for investors interested in comparing ABEO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ABEO versus a peer is one thing; comparing ABEO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ABEO can fluctuate over the course of history. With this page we aim to empower investors researching ABEO by allowing them to research the ABEO market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ABEO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Abeona Therapeutics (ABEO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ABIO Market Cap History
ABMD Market Cap History
ABOS Market Cap History
ABSI Market Cap History
ABT Market Cap History
ABVC Market Cap History
ACAD Market Cap History
ACCD Market Cap History
ACER Market Cap History
ACET Market Cap History
More Healthcare companies »


ABEO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.